M. C. Genovese, M. W. Greenwald, C. S. Cho, A. Berman, L. Jin, G. Cameron, et al., “A Phase 2 Study of Multiple Subcutaneous Doses of LY2439821, an Anti-IL-17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis in Two Populations Nave to Biologic Therapy or Inadequate Responders to Tumor Necrosis Factor Alpha Inhibitors [abstract],” Arthritis and Rheumatism, Vol. 63, No. S10, 2011, p. S1017. - References - Scientific Research Publishing